Effects of increased accumulation of doxorubicin due to emodin on efflux transporter and LRP1 expression in lung adenocarcinoma and colorectal carcinoma cells

Combination therapy in combating cancer

(2017) Reza Bayat Mokhtari et al.   Oncotarget

Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation

(2016) Xinxing Li et al.   BMC CANCER

Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin

(2013) Tae Hyung Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review)

(2013) WEI-TIAN WEI et al.   ONCOLOGY REPORTS

Side Population Cells as Prototype of Chemoresistant, Tumor-Initiating Cells

(2013) Vinitha Richard et al.   Biomed Research International

Exploration of effects of emodin in selected cancer cell lines: enhanced growth inhibition by ascorbic acid and regulation of LRP1 and AR under hypoxia-like conditions

(2012) Shashank Masaldan et al.   JOURNAL OF APPLIED TOXICOLOGY

Role of LRP1 in transport of CCN2 protein in chondrocytes

(2012) Kazumi Kawata et al.   JOURNAL OF CELL SCIENCE

Emodin As an Effective Agent in Targeting Cancer Stem-Like Side Population Cells of Gallbladder Carcinoma

(2012) Xin-xing Li et al.   STEM CELLS AND DEVELOPMENT

Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: The mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1

(2010) Xin-zhi Huang et al.   CANCER BIOLOGY & THERAPY

Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation

(2009) Wei Wang et al.   BIOCHEMICAL PHARMACOLOGY

Emodin Has Cytotoxic and Protective Effects in Rat C6 Glioma Cells: Roles of Mdr1a and Nuclear Factor  B in Cell Survival

(2009) T.-C. Kuo et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Emodin induces apoptosis in human prostate cancer cell LNCaP

(2008) Chun-Xiao Yu et al.   ASIAN JOURNAL OF ANDROLOGY

Treatment of resistant human colon cancer xenografts by a fluoxetine–doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen

(2008) Mirit Argov et al.   CANCER LETTERS